News
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...
PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks that Jim Cramer recently commented on. During the episode, Cramer noted that ...
Explore more
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
A recent study revealed that individuals taking weight-loss drugs, including renowned GLP-1s, may significantly regain weight ...
University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology.Video above: Weight-loss ...
While the study participants who took semaglutide lost more weight than those who followed the diet and lifestyle program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results